The approval is a long time coming for ImmunityBio after the FDA rejected Anktivas Biologics License Application in May 2023 due to issues with a pre-license inspection of a third-party manufacturer
doi: 10.3389/fmed.2023.1116489 Received 05 December 2022 Accepted 18 January 2023 Published 02 February 2023 Volume 10 - 2023 Edited by Hoon Young Choi, Yonsei University, Republic of Korea Reviewed by Nagwa Ali Sabri, Ain Shams University, Egypt
BPC-157 appears in research contexts involving gastric peptide research, tissue-repair models, tendon/ligament pathway studies, inflammatory response research
Animal studies [5] suggest localized injections may have greater effects on muscles, tendons and ligaments, but safety and efficacy in humans are still under investigation
In fact, studies have found that high intakes of vitamin A, vitamin C and other antioxidant foods could help prevent or treat several forms of cancer thanks to their ability to control malignant cells in the body and cause cell cycle arrest and apoptosis (destruction) of cancer cells
